TABLE 1.
Base line characteristics of patients infected with HBV infection (n‐159).
| Characteristics | Value |
|---|---|
| Age (year) a | 34 (18–56) |
| Sex‐Male‐n (%) | 138 (86.8%) |
| BMI (kg/m2) b | 24.5 ± 3.7 |
| Risk factors‐n (%) | |
| Blood transfusion | 0 (0%) |
| Unprotected sex | 4 (2.5%) |
| Tattoo | 4 (2.5%) |
| Surgery | 4 (2.5%) |
| IDU | 0 (0%) |
| Family history‐n (%) | |
| HBV infection | 11 (6.9%) |
| Hepatocellular carcinoma | 3 (1.8%) |
| Death due to decompensated liver disease | 3 (1.8%) |
| Addiction‐n (%) | |
|
Alcohol Smoking Others |
17 (10.7%) 16 (10.1%) 0 (0%) |
| Total Bilirubin b | 0.81 ± 0.6 |
| ALT (U/L) 1 | 33 (12–221) |
| AST (U/L) 1 | 34 (16–126) |
| Total protein (gm/dl) b | 7.5 ± 0.52 |
| Albumin (gm/dl) b | 4.2 ± 0.35 |
|
APRI 2 < 1.5 1.5–2 > 2 |
0.54 ± 0.32 155 (97.5%) 4 (2.5%) Nil |
|
FIB4 b < 1.45 (n) 1.45–3.25 (n) > 3.25 (n) |
1.25 ± 0.75 146 (91.8%) 8 (5.0%) 5 (3.1%) |
|
LSM (kPa) b (n − 61) < 8 (n) 8–12.5 (n) > 12.5 (n) |
5.7 ± 1.7 54 (88.5%) 6 (9.8%) 1 (1.7%) |
|
HBV DNA (IU/ml) (n) > 20 000 2000–20 000 20–2000 < 20 (BDL) |
32 (20%) 34 (21%) 81 (51%) 12 (8%) |
|
HBeAg status (n) HBeAg negative HBeAg positive Not known |
130 116 (89%) 14 (11%) 29 |
| Cirrhosis (compensated) (n) | 9 (6.7%) |
| No cirrhosis (n) | 150 (94.3%) |
| Treatment eligible (n) | 34 (21.3%) |
| Treatment initiated (n) | 34 (21.3%) |
Abbreviations: BDL‐below detection level; n‐no. of persons.
a
Median (range).
b
Mean + ‐SD.